Schafer Boeder, MD

Endocrinologist and #T1D researcher @UCSDHealth pursuing new treatments and technologies for people with diabetes. Views and opinions are my own.

[Schafer Boeder, MD @DrBoeder]

@BCBacker BCB, why do you scale out at specific price targets rather than setting stop losses / trailing stop losses once an asset reaches its targets?

[Schafer Boeder, MD @DrBoeder]

Urge Congress to Support the SCREEN for Type 1 Diabetes Act - Breakthrough T1D https://t.co/KhJBrhMYU6

[Schafer Boeder, MD @DrBoeder]

Nice summary and commentary on the new @AmDiabetesAssn DKA and HHS guidelines

[Vin Tangpricha, MD, PhD @vtangpricha]

New commentary on the ADA guidelines on DKA #EndocrinePractice by Drs Swapnil Khare, Garg, Shah and @zilbermint Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report https://t.co/hwMhgCJ7Sd

[Schafer Boeder, MD @DrBoeder]

@TXMCtrades More please

[Schafer Boeder, MD @DrBoeder]

@AlexR_L @PhDVoice @PatientAdvStrat They should ask their provider that question, and if they don't have a good answer (e.g. no other option due to cost or contraindications), then maybe find a new doc 🤔

[Schafer Boeder, MD @DrBoeder]

This should be a great talk from @AhnCall. I wish I could be there to see it!

[David Ahn, MD @AhnCall]

I’ll be speaking about "The Role of Continuous Glucose Monitoring in Obesity Management" at the #ObesityMedicine2023 Conference in New York, April 19-23! Join me and @omasocial as we discuss how to effectively treat obesity in all patients. #OMA2023 #CGM

https://t.co/1gErs122BS

[Daniel J Drucker @DanielJDrucker]

Congratulations to Professor Silva Arslanian 2023 awardee for Outstanding Achievement in Clinical Diabetes Research Awardee @AmDiabetesAssn @UPMCnews and Dr. Raghavendra G. Mirmira, 2023 Albert Renold Awardee @KovlerDiabetes @rmirmira #diabetes

[Schafer Boeder, MD @DrBoeder]

Happy to share our new publication in @Diabetes_Ther. Thanks to my co-authors for their valuable perspectives!

[Diabetes Therapy @Diabetes_Ther]

This article shares perspectives from a person living with #Type2Diabetes, a nurse practitioner/Certified #Diabetes Care and Education Specialist & a clinical #endocrinologist. It aims to provide HCPs with guidance on optimizing rapport with their patient: https://t.co/HdfmaPI7MN

[Schafer Boeder, MD @DrBoeder]

Thanks for the update @TCOYD. Very exciting news in the #T1D space!

[TCOYD @TCOYD]

Breaking news: The FDA has just approved Tzield (teplizumab) as the first-ever disease-modifying therapy to delay the onset of type 1 diabetes. To learn more about screening for T1D & Tzield as a potential therapeutic option to delay the onset of T1D visit https://t.co/vsfN8xwOOM

[Schafer Boeder, MD @DrBoeder]

Awesome article from @TCOYD about #weightloss and #diabetes. Discusses nutrition, physical activity, and medications that can help!

[TCOYD @TCOYD]

Most people have struggled with weight in some way at some time. If you have some pounds to lose & don't know where to begin, there are many tools & medication options available, including a newer GLP-1 RA that also helps control blood sugars. Learn more: https://t.co/hl9w0a3uUy

[Schafer Boeder, MD @DrBoeder]

Excited for this news from @CollegeDiabetes! The (newly named) Diabetes Link is working to be inclusive of all young adults with #T1D

[The Diabetes Link @thediabeteslink]

After 12 years serving 11,500+ students across 30 states, College Diabetes Network is expanding. While CDN has made progress with students with type 1 diabetes, there is a need & opportunity to LINK all young adults with diabetes to the support & resources they need to thrive.

[Schafer Boeder, MD @DrBoeder]

@T1DExchange Shocked that only 3% report diabetes distress!

[Nature Reviews Endocrinology @NatureRevEndo]

Glucagon receptor antagonist volagidemab in type 1 #diabetes: a 12-week, randomized, double-blind, phase 2 trial https://t.co/f7lLxiQVUv via @NatureMedicine

[NEJM @NEJM]

In a 13-week, randomized trial involving persons 6 to 79 years of age with type 1 diabetes, use of a bionic pancreas was associated with a greater reduction in the glycated hemoglobin level than standard care. https://t.co/BHyBKxqSWP

[Schafer Boeder, MD @DrBoeder]

@TXMCtrades Wouldn't this argue that since both the boomers and the millennial are trying to buy houses, there are actually two huge generations to keep the demand (relatively) high?

[Schafer Boeder, MD @DrBoeder]

@TXMCtrades Aren't there a ton of millennials entering prime home buying age now tho?

[Schafer Boeder, MD @DrBoeder]

@CredibleCrypto @Grayscale OK that was simpler than I expected. Thanks my man 🤙

[Schafer Boeder, MD @DrBoeder]

@philnice272 Two cuties 😚